血清锌α2糖蛋白与2型糖尿病患者空腹C肽、血尿酸水平的相关性研究

doi:10.3760/cma.j.issn.1007-1245.2022.01.019

国际医药卫生导报 ›› 2022, Vol. 28 ›› Issue (1): 79-81.DOI: 10.3760/cma.j.issn.1007-1245.2022.01.019

血清锌α2糖蛋白与2型糖尿病患者空腹C肽、血尿酸水平的相关性研究

吴敏, 黄淑玉, 王星, 邹毅, 胡小平, 姜静雯, 廖世波, 朱钊, 黄高, 李玲

武汉科技大学附属孝感医院内分泌科，孝感　432000

收稿日期:2021-08-31 出版日期:2022-01-01 发布日期:2022-02-01
通讯作者: 吴敏，Email：minwuy@126.com
基金资助:
孝感市自然科学计划项目（XGKJ2019010007）

Correlation of zinc-a2-glycoprotein with C-peptide and uric acid in patients type 2 diabetes mellitus

Wu Min, Huang Shuyu, Wang Xing, Zou Yi, Hu Xiaoping, Jiang Jingwen, Liao Shibo, Zhu Zhao, Huang Gao, Li Ling

Department of Endocrinology, Affiliated Xiaogan Hospital of Wuhan University of Science and Technology, Xiaogan 432000, China

Received:2021-08-31 Online:2022-01-01 Published:2022-02-01
Contact: Wu Min，Email：minwuy@126.com
Supported by:
Project of Natural Science Plan in Xiaogan (XGKJ2019010007)

摘要/Abstract

摘要： 目的　观察探讨血清锌a2糖蛋白（ZAG）与2型糖尿病（T2DM）患者空腹C肽、血尿酸（SUA）水平的相关性，为预防T2DM患者高尿酸血症（HUA）及并发症的发生提供理论依据。方法　选取2019年5月至2021年5月在武汉科技大学附属孝感医院内分泌科住院的2型糖尿病患者110例为研究对象，根据是否合并HUA分为两组，观察组：T2DM并HUA组54例，年龄（55.2±6.68）岁，男28例，女26例；对照组：T2DM尿酸正常组56例，年龄（55.8±5.80）岁，男28例，女28例。均测定空腹血清ZAG、C肽、血糖、血脂、糖化血红蛋白及其他相关临床指标。数据采用SPSS 17.0软件，组间比较采用独立样本t检验、χ²检验和非参数检验，ZAG与临床其他指标分别进行偏相关分析和多元性逐步回归分析。结果　观察组患者空腹血清ZAG水平明显高于对照组［（60.01±24.56）mg/L比（44.35±17.20）mg/L，P<0.05］。T2DM患者空腹血清ZAG水平分别与SUA（r=0.543）、体质量指数（r=0.240）、C肽（r=0.437）、三酰甘油（r=0.372）呈正相关，与高密度脂蛋白胆固醇呈负相关（r=-0.447），差异均有统计学意义（均P<0.05）。结论　T2DM并HUA患者较T2DM尿酸正常者血清ZAG表达水平升高；ZAG可能诱导T2DM患者糖脂代谢紊乱，参与胰岛素抵抗过程，增加SUA表达，可能成为预防及治疗HUA及其相关代谢性疾病的新靶点。

关键词: 2型糖尿病, 高尿酸血症, 锌a2糖蛋白, 空腹C肽, 血尿酸

Abstract: Objective　To investigate the correlation of zinc-a2-glycoprotein with C-peptide and serum uric acid (SUA) in patients type 2 diabetes mellitus (T2DM), and to provide theoretical references in the prevention of hyperuricemia and its complications in patients with T2DM. Methods　From May 2019 to May 2021, 110 patients with T2DM treated at Department of Endocrinology, Affiliated Xiaogan Hospital of Wuhan University of Science and Technology were chosen, and were divided into an observation group (54 cases,including 28 males and 26 females), the ones complicated with hyperuricemia who were (55.2±6.68) years old, and a control group (56 cases, including 28 males and 28 female), the ones not complicated with hyperuricemia who were (55.8±5.80) years old, cases, according to whether they were complicated with hyperuricemia. The fasting serum levels of ZAG, C-peptide, and plasma glucose (FPG), glycosylated emoglobin A1c (HbA1c), blood lipid, and related clinical indicators were detected. The data were analyzed by the software SPSS 17.0. The independent-sample t , χ², and nonparamertric tests were used for the comparison between these two groups. Partial correlation analysis and multiple stepwise regression analysis were used to analyze the ZAG and other clinical indicators. Results　The fasting serum level of ZAG in the observation group was higher in than that in the control group [(60.01±24.56) mg/L vs. (44.35±17.20) mg/L, P<0.05]. The fasting serum level of ZAG in the patients with T2DM was positively correlated with SUA (r=0.543), body mass index (r=0.240), C-peptide (r=0.437), and triacylglycerol (r=0.372), and negatively with high density liptein cholesterol (r=-0.447), with statistical differences (all P<0.05). Conclusions　The serum level of ZAG in the T2DM patients with hyperuricemia is higher than that in the ones with no hyperuricemia. ZAG may induce lipid metabolism disorder in T2DM patients, participate in insulin resistance, and increase SUA, so it could be a new target in the prevention and treatment of hyperuricemia and other metabolism diseases.

Key words: Type 2 diabetes mellitus, Hyperuricemia, Zinc-a2-glycoprotein, Fasting C-peptide, Serum uric acid

吴敏, 黄淑玉, 王星, 邹毅, 胡小平, 姜静雯, 廖世波, 朱钊, 黄高, 李玲. 血清锌α2糖蛋白与2型糖尿病患者空腹C肽、血尿酸水平的相关性研究[J]. 国际医药卫生导报, 2022, 28(1): 79-81.

Wu Min, Huang Shuyu, Wang Xing, Zou Yi, Hu Xiaoping, Jiang Jingwen, Liao Shibo, Zhu Zhao, Huang Gao, Li Ling. Correlation of zinc-a2-glycoprotein with C-peptide and uric acid in patients type 2 diabetes mellitus[J]. International Medicine and Health Guidance News, 2022, 28(1): 79-81.

参考文献

[1] Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030[J]. Diabetes Res Clin Pract, 2011,94(3):311-321. DOI: 10.1016/j.diabres.2011.10.029.

[2] 吴敏,黄淑玉,晏益民,等.新诊断2型糖尿病伴高尿酸血症与血压及血脂相关性分析[J].国际医药卫生导报,2016,22(10):1406-1408.DOI:10.3760/cma.j.issn.1007-1245. 2016.10.023.

[3] 李白洁,范志宏.锌α2糖蛋白与2型糖尿病关系的研究进展[J].中国糖尿病杂志,2016,24(8):757-759.DOI:10.3969/j.issn.1006-6187.2016.08.022.

[4] 邬丹,刘宏,李申恒.尿酸与2型糖尿病代谢紊乱及危险因素分析[J].南方医科大学学报,2011,31(3):544-547.DOI:10.12122/j.issn.1673-4254.2011.03.036.

[5] 中国医师协会肾脏内科医师分会.中国肾脏疾病高尿酸血症诊治的实践指南(2017版)[J].中华医学杂志,2017,97(25):1927-1936.DOI:10.3760/cma.j.issn.0376-2491. 2017.25.003.

[6] Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes[J]. Diabet Med, 2013,30(7):803-817. DOI: 10.1111/dme.12159.

[7] Cabrera de León A, Oliva García JG, Marcelino Rodríguez I, et al. C-peptide as a risk factor of coronary artery disease in the general population[J]. Diab Vasc Dis Res, 2015,12(3):199-207. DOI: 10.1177/1479164114564900.

[8] Zhu HJ, Ding HH, Deng JY, et al. Inhibition of preadipocyte differentiation and adipogenesis by zinc-α2-glycoprotein treatment in 3T3-L1 cells[J]. J Diabetes Investig, 2013,4(3):252-60. DOI: 10.1111/jdi.12046.

[9] Barrea L, Marzullo P, Muscogiuri G, et al. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome[J]. Nutr Res Rev, 2018,31(2):291-301. DOI: 10.1017/S0954422418000136.

[10] 杨洁,刘李文韬,陈秉朴,等.锌α2糖蛋白与高尿酸血症的相关性研究[J].医学研究生学报,2017,30(2):173-176.DOI:10.16571/j.cnki.1008-8199.2017.02.013.

血清锌α2糖蛋白与2型糖尿病患者空腹C肽、血尿酸水平的相关性研究

Correlation of zinc-a2-glycoprotein with C-peptide and uric acid in patients type 2 diabetes mellitus

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics